Abstract:This review comprehensively summarizes the advances in research for fibrosis. It emphasizes organ‐specific profibrotic cell types and molecular mechanisms of fibrosis, especially in the kidney, liver, lung, and heart. The authors highlight the advanced antifibrotic small molecule drugs and cellular therapies for fibrosis. These findings have critical implications for further research and clinical translation of medicine. As the final stage of disease‐related tissue injury and repair, fibrosis is characterized by excessive accumulation of the extracellular matrix. Unrestricted accumulation of stromal cells and matrix during fibrosis impairs the structure and function of organs, ultimately leading to organ failure. The major etiology of fibrosis is an injury caused by genetic heterogeneity, trauma, virus infection, alcohol, mechanical stimuli, and drug. Persistent abnormal activation of "quiescent" fibroblasts that interact with or do not interact with the immune system via complicated signaling cascades, in which parenchymal cells are also triggered, is identified as the main mechanism involved in the initiation and progression of fibrosis. Although the mechanisms of fibrosis are still largely unknown, multiple therapeutic strategies targeting identified molecular mechanisms have greatly attenuated fibrotic lesions in clinical trials. In this review, the organ‐specific molecular mechanisms of fibrosis is systematically summarized, including cardiac fibrosis, hepatic fibrosis, renal fibrosis, and pulmonary fibrosis. Some important signaling pathways associated with fibrosis are also introduced. Finally, the current antifibrotic strategies based on therapeutic targets and clinical trials are discussed. A comprehensive interpretation of the current mechanisms and therapeutic strategies targeting fibrosis will provide the fundamental theoretical basis not only for fibrosis but also for the development of antifibrotic therapies.

Research Progress on the Mechanism of Angiocrine Factors Regulating Lung Regeneration and Fibrosis

Lung regeneration: diverse cell types and the therapeutic potential

Stem Cells In Lung Repair And Regeneration: Current Applications And Future Promise

Repairing Mechanisms for Distal Airway Injuries and Related Targeted Therapeutics for Chronic Lung Diseases

Targeting of the Pulmonary Capillary Vascular Niche Promotes Lung Alveolar Repair and Ameliorates Fibrosis

Comprehensive Review of the Vascular Niche in Regulating Organ Regeneration and Fibrosis

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies

Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis

Angiogenesis-An Emerging Role in Organ Fibrosis

Pulmonary endogenous progenitor stem cell subpopulation: Physiology, pathogenesis, and progress

Past and Future of Alveolar Organoids for Lung Regenerative Medicine

Biomechanical Properties and Cellular Responses in Pulmonary Fibrosis

Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis

Advanced 3D In Vitro Lung Fibrosis Models: Contemporary Status, Clinical Uptake, and Prospective Outlooks

Update on Implications and Mechanisms of Angiogenesis in Liver Fibrosis

Angiotensin signalling in pulmonary fibrosis

Age-Dependent Inflammatory Microenvironment Mediates Alveolar Regeneration

Notch signaling regulates pulmonary fibrosis

New Therapeutic Approaches Against Pulmonary Fibrosis.

Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities

Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review